vs
AVADEL PHARMACEUTICALS PLC（AVDL）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
AVADEL PHARMACEUTICALS PLC的季度营收约是REGIS CORP的1.4倍（$77.5M vs $57.1M），REGIS CORP净利率更高（0.8% vs 0.0%，领先0.8%），AVADEL PHARMACEUTICALS PLC同比增速更快（54.9% vs 22.3%），AVADEL PHARMACEUTICALS PLC自由现金流更多（$22.2M vs $891.0K），过去两年AVADEL PHARMACEUTICALS PLC的营收复合增速更高（99.6% vs 7.8%）
Avadel Pharmaceuticals是爱尔兰的专科制药企业，专注于睡眠障碍治疗药物的研发，产品覆盖医院及基层医疗场景，总部位于爱尔兰都柏林，在美国密苏里州圣路易斯、法国里昂均设有业务运营点。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
AVDL vs RGS — 直观对比
营收规模更大
AVDL
是对方的1.4倍
$57.1M
营收增速更快
AVDL
高出32.6%
22.3%
净利率更高
RGS
高出0.8%
0.0%
自由现金流更多
AVDL
多$21.3M
$891.0K
两年增速更快
AVDL
近两年复合增速
7.8%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $77.5M | $57.1M |
| 净利润 | $20.0K | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 2.5% | 10.8% |
| 净利率 | 0.0% | 0.8% |
| 营收同比 | 54.9% | 22.3% |
| 净利润同比 | 100.8% | -94.0% |
| 每股收益（稀释后） | $0.00 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVDLRGS
| Q4 25 | — | $57.1M | ||
| Q3 25 | $77.5M | $59.0M | ||
| Q2 25 | $68.1M | $60.4M | ||
| Q1 25 | $52.5M | $57.0M | ||
| Q4 24 | $50.4M | $46.7M | ||
| Q3 24 | $50.0M | $46.1M | ||
| Q2 24 | $41.5M | $49.4M | ||
| Q1 24 | $27.2M | $49.2M |
净利润AVDLRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $20.0K | $1.4M | ||
| Q2 25 | $9.7M | $116.5M | ||
| Q1 25 | $-4.9M | $250.0K | ||
| Q4 24 | $-5.0M | $7.6M | ||
| Q3 24 | $-2.6M | $-853.0K | ||
| Q2 24 | $-13.8M | $91.2M | ||
| Q1 24 | $-27.3M | $-2.3M |
毛利率AVDLRGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q1 25 | 89.4% | — | ||
| Q4 24 | 90.5% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | 93.3% | — | ||
| Q1 24 | 94.4% | — |
营业利润率AVDLRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | 2.5% | 10.0% | ||
| Q2 25 | 13.0% | 12.1% | ||
| Q1 25 | -5.7% | 8.8% | ||
| Q4 24 | -6.5% | 11.8% | ||
| Q3 24 | -0.7% | 4.6% | ||
| Q2 24 | -30.7% | — | ||
| Q1 24 | -95.8% | 8.3% |
净利率AVDLRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 14.2% | 192.9% | ||
| Q1 25 | -9.4% | 0.4% | ||
| Q4 24 | -10.0% | 16.4% | ||
| Q3 24 | -5.2% | -1.9% | ||
| Q2 24 | -33.3% | 184.7% | ||
| Q1 24 | -100.6% | -4.7% |
每股收益（稀释后）AVDLRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | $0.00 | $0.49 | ||
| Q2 25 | $0.10 | $43.67 | ||
| Q1 25 | $-0.05 | $0.08 | ||
| Q4 24 | $-0.04 | $2.71 | ||
| Q3 24 | $-0.03 | $-0.36 | ||
| Q2 24 | $-0.14 | $38.40 | ||
| Q1 24 | $-0.30 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.6M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $98.2M | $188.7M |
| 总资产 | $199.4M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资AVDLRGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | $91.6M | $16.6M | ||
| Q2 25 | $81.5M | $17.0M | ||
| Q1 25 | $66.5M | $13.3M | ||
| Q4 24 | $73.8M | $10.2M | ||
| Q3 24 | $65.8M | $6.3M | ||
| Q2 24 | $71.4M | $10.1M | ||
| Q1 24 | $88.8M | $5.9M |
总债务AVDLRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益AVDLRGS
| Q4 25 | — | $188.7M | ||
| Q3 25 | $98.2M | $187.6M | ||
| Q2 25 | $90.7M | $185.6M | ||
| Q1 25 | $74.1M | $68.6M | ||
| Q4 24 | $73.8M | $66.7M | ||
| Q3 24 | $74.7M | $56.4M | ||
| Q2 24 | $70.3M | $56.8M | ||
| Q1 24 | $78.4M | $-35.8M |
总资产AVDLRGS
| Q4 25 | — | $588.3M | ||
| Q3 25 | $199.4M | $592.1M | ||
| Q2 25 | $187.2M | $599.0M | ||
| Q1 25 | $167.9M | $511.2M | ||
| Q4 24 | $164.2M | $530.1M | ||
| Q3 24 | $158.3M | $508.9M | ||
| Q2 24 | $157.5M | $530.5M | ||
| Q1 24 | $167.9M | $543.7M |
负债/权益比AVDLRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.2M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $22.2M | $891.0K |
| 自由现金流率自由现金流/营收 | 28.7% | 1.6% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 1110.25× | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流AVDLRGS
| Q4 25 | — | $1.7M | ||
| Q3 25 | $22.2M | $2.3M | ||
| Q2 25 | $12.7M | $6.8M | ||
| Q1 25 | $-8.2M | $6.2M | ||
| Q4 24 | $7.9M | $2.1M | ||
| Q3 24 | $-6.9M | $-1.3M | ||
| Q2 24 | $-18.2M | $5.1M | ||
| Q1 24 | $-29.7M | $-277.0K |
自由现金流AVDLRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | $22.2M | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率AVDLRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | 28.7% | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度AVDLRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率AVDLRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 1110.25× | 1.68× | ||
| Q2 25 | 1.31× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVDL
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
